These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 686441)

  • 1. Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity.
    Sunew KY; Hicks RG
    Anesthesiology; 1978 Sep; 49(3):188-91. PubMed ID: 686441
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure.
    Bishop MJ; Hornbein TF
    Anesthesiology; 1983 Apr; 58(4):384-6. PubMed ID: 6340560
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight, pseudocholinesterase activity, and succinylcholine requirement.
    Bentley JB; Borel JD; Vaughan RW; Gandolfi AJ
    Anesthesiology; 1982 Jul; 57(1):48-9. PubMed ID: 7091721
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged response to succinylcholine following physostigmine.
    Kopman AF; Strachovsky G; Lichtenstein L
    Anesthesiology; 1978 Aug; 49(2):142-3. PubMed ID: 686422
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudocholinesterase activity and atracurium v. suxamethonium block.
    Baraka A; Wakid N; Noueihed R; Karam H; Bolotova N
    Br J Anaesth; 1986; 58 Suppl 1():91S-95S. PubMed ID: 3011044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
    Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
    Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of suxamethonium, pancuronium, neostigmine and halothane on serum cholinesterase activity.
    Choudhury KJ; Mosuro OS; Ffoulkes-Crabbe DJ
    Middle East J Anaesthesiol; 1989 Oct; 10(3):315-21. PubMed ID: 2637954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of anticholinesterases on the neuromuscular block produced by suxamethonium.
    KOHN R; BOVET D
    J Pharm Pharmacol; 1956 May; 8(5):309-17. PubMed ID: 13320312
    [No Abstract]   [Full Text] [Related]  

  • 11. Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1977 May; 49(5):479-84. PubMed ID: 861116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolonged apnea after suxamethonium related to congenital abnormality of plasma pseudocholinesterase].
    Velin P; Dupont D
    Ann Fr Anesth Reanim; 1989; 8(1):73-4. PubMed ID: 2712406
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenobarbital or diazepam therapy and plasma pseudocholinesterase activity.
    Stoelting RK; Peterson C
    Anesthesiology; 1975 Mar; 42(3):356-7. PubMed ID: 1115389
    [No Abstract]   [Full Text] [Related]  

  • 14. The action of facilitatory drugs and acetylcholine on neuromuscular transmission.
    Riker WF; Standaert FG
    Ann N Y Acad Sci; 1966 Jan; 135(1):163-76. PubMed ID: 5221338
    [No Abstract]   [Full Text] [Related]  

  • 15. [Atypical cholinesterases: investigation using the dibucaine test].
    Tramontano R; Pagani L; Castellana A; Cesari M
    Minerva Anestesiol; 1985; 51(1-2):5-7. PubMed ID: 4022405
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of neostigmine and pyridostigmine on serum cholinesterase activity.
    Mirakhur RK; Lavery TD; Briggs LP; Clarke RS
    Can Anaesth Soc J; 1982 Jan; 29(1):55-8. PubMed ID: 7055744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of some cholinergic agonists and anticholinesterase agents on the dorsal muscle of the leech.
    Flacke W; Yeoh TS
    Br J Pharmacol Chemother; 1968 May; 33(1):145-53. PubMed ID: 5660154
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of succinyldithiocholine hydrolysis by serum cholinesterase: comparison to dibucaine and succinylcholine numbers.
    Hersh LB; Raj PP; Ohlweiler D
    J Pharmacol Exp Ther; 1974 May; 189(2):544-9. PubMed ID: 4829230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetic and acquired variations in butyrylcholinesterases].
    Leprince A; Josancy M; Allain P; Léonardon P; Martin P
    Cah Anesthesiol; 1985 Nov; 33(7):619-21. PubMed ID: 4092163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of cholinesterase in the myoneural synapses by decamethonium and ditilin].
    Danilov AF
    Farmakol Toksikol; 1967; 30(6):664-9. PubMed ID: 5598433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.